Colin has been the managing director of Théa Open Innovation since 2019. Prior to that, Colin was Head of Business Development at Laboratoires Théa. Previously, he had held R&D positions at INSERM, Sanofi, Laboratoires Servier and Laboratoires Théa. He was trained as a biomedical engineer (Ecole Centrale de Lyon and Claude Bernard University). Colin is also the general manager of the company Sincler, and member of the board of Ripple Therapeutics.